Navigation Links
FDA Gives Nod to Botox to Treat Overactive Bladder

FRIDAY, Jan. 18 (HealthDay News) -- The U.S. Food and Drug Administration on Friday gave its approval for the use of Botox against a form of urinary incontinence known as overactive bladder.

"Clinical studies have demonstrated Botox's ability to significantly reduce the frequency of urinary incontinence," Dr. Hylton Joffe, director of the Division of Reproductive and Urologic Products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

"Today's approval provides an important additional treatment option for patients with overactive bladder, a condition that affects an estimated 33 million men and women in the United States," he added.

Overactive bladder is a condition where the bladder contracts too frequently or without warning, causing incontinence, sudden/urgent urge to urinate and frequent urination.

However, injections of Botox (onabotulinumtoxinA) into the bladder muscle can trigger a relaxation of the bladder, boost the organ's storage capacity and make incontinence episodes less frequent, the FDA said.

Physicians inject the drug while using cytoscopy, a procedure that allows the doctor to visualize the interior of the bladder as injection occurs.

The FDA said the safety and effectiveness of Botox for this use was verified in two clinical trials involving more than 1,100 patients with overactive bladder, with patients receiving either 100 units of Botox (20 injections of 5 units each) or a placebo.

Lasting more than three months, the trials found that Botox patients experienced close to two fewer bouts of urinary incontinence a day compared to those on a placebo, had fewer urinations per day, and an average of 30 milliliters more urine expelled each day, compared to those on a placebo.

Side effects included urinary tract infections, painful urination and incomplete emptying of the bladder, the FDA said. People who already have a urinary tract infection should not take Botox for overactive bladder, and people who do take the drug should take antibiotics before, during and for a few days after the procedure, the agency added.

Botox, best known for its ability to temporarily smooth away facial lines and wrinkles, is made by Allergan Inc. of Irvine, Calif.

More information

Find out more about overactive bladder at the American Urological Association.

-- E.J. Mundell

SOURCE: Jan. 18, 2013, news release, U.S. Food and Drug Administration

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Author of the Uplifting Cancer Survival Guide, The C Card and Me, Gives Her Book Away to Millions
2. U.S. Gives States More Time to Set Up Health Insurance Exchanges
3. Wake-Up Call: Medical Malpractice Attorneys at Console & Hollawell Express Concern After Surgeon Gives Hepatitis B to Patients
4. CPS Magazine Announces a CDT Code for Resin Infiltration that Gives Dental Practices Additional Treatment and Billing Options for New Dental Material Icon by DMG America
5. Fit and Healthy with Beth gives Her Tips to Stay Stress Free this Holiday Season
6. What Causes Hot Flashes? Rat Study Gives New Clues
7. Carolina Women's Physicians Gives Key Tips for Eating Healthy During the Holiday Season
8. I Fly First Class Gives New Tips on How to Avoid Sickness and be Prepared for Your Next Trip
9. No Proof That Doping With EPO Gives Athletes an Edge: Review
10. Mitchell Vazquez Gives Away Donations to Advance Cancer Research Cause
11. Synchrotron gives insight into green energy enzymes
Post Your Comments:
Related Image:
FDA Gives Nod to Botox to Treat Overactive Bladder
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... water accessible for all, Water For Empowerment ™ attracts volunteers together who ... clean water by empowering women as key stakeholders in the process. The non-profit ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  The total global healthcare industry is expected to ... Latin America has the highest projected growth ... Japan ), is second with growth projected at ... increased healthcare expenditure. In 2013-2014, total government funded healthcare was ... 2008-2009 to 41.2% in 2013-2014. In real terms, out of ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
Breaking Medicine Technology: